The LARGEST human study on Ivermectin + Mebendazole for cancer is now peer-reviewed and published in a major oncology journal.
84.4% of patients reported COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH.
Patients took 25 mg Ivermectin and 250 mg Mebendazole. After 6 months, patients had an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
Cancer stabilization (36.1%)
Cheap. Off-patent. Widely available.
Yet for years it was viciously attacked, censored, and ridiculed as “horse paste” while millions died from cancer — and the industry made trillions pushing toxic chemo and lifelong “treatments.”
This wasn’t an accident.
They don’t want cures.
They want customers.
The dam has broken and the suppression is being exposed.
INSTEAD OF WATCHING AN HOUR OF NETFLIX TONIGHT.
This 1 hour Stanford lecture by Joel Peterson will teach you more about negotiation and getting what you want than most people learn in years.
Bookmark it and give it an hour, no matter what.
The LARGEST human ivermectin cancer study EVER done found 84.4% of patients declared their cancer had COMPLETELY DISAPPEARED, SHRUNK, or STOPPED PROGRESSING after 6 months.
Our study is now PEER-REVIEWED and PUBLISHED by the International Institute of Anticancer Research.
Dandelion root ELIMINATES over 95% of cancer cells in the lab and SLASHES human colon tumor growth in mice by over 90% with ZERO harm to healthy cells.
Canada approved human trials in 2012… yet they mysteriously NEVER happened.
Common backyard plants terrify the Chemo Cartel.
A SINGLE dose of a newly discovered frog gut bacterium ELIMINATES 100% of cancerous tumors within just a few days in mice.
A new landmark study found the natural bacterium Ewingella americana selectively targets, colonizes, and terminates tumors—with NO detectable toxicity.
They re-introduced cancer into the cured animals... and the tumors COULD NOT GROW.
The conspiracy theorists were right
A new FDA data mining report shows they knew the Covid vaccine had 25 major side effects and they all conspired to hide it from the public
Senator Ron Johnson’s Senate PSI Majority Staff Interim Report has been released on FDA data mining and the March 2021 analysis by Dr. Ana Szarfman
There was a “masking” in the standard FDA system, where signals from Pfizer and Moderna reportedly cancelled each other out
Meaning they lied and hid the side effects from the public and told you it was 100% safe and effective
I have compared the whole list for you:
Neurological & Dysautonomia
• Bell’s palsy (Suppressed Signal)
• Paraesthesia ear (Suppressed Signal)
• Bradykinesia (Suppressed Signal)
• Basal ganglia stroke (Suppressed Signal)
• Cerebral artery occlusion (Suppressed Signal)
• Thalamic infarction
• Sinus rhythm abnormality
• Agonal rhythm
• Diaphragmatic spasm
• Dementia (Pfizer)
Cardiac
• Sudden cardiac death (Suppressed Signal)
• Acute left ventricular failure (Suppressed Signal)
• Diastolic dysfunction (Suppressed Signal)
• Ejection fraction abnormal (Suppressed Signal)
• Hypertensive emergency (Suppressed Signal)
• Blood pressure systolic changes (Suppressed Signal)
• Aortic stenosis (Suppressed Signal)
• Cardiac failure chronic
• Acute myocardial infarction (Pfizer, Moderna)
• Cardiac telemetry abnormal (Pfizer) (Suppressed Signal)
Vascular & Pulmonary
• Pulmonary infarction (Suppressed Signal)
• Embolic stroke
• Ischaemic stroke
• Aortic aneurysm rupture
• May-Thurner syndrome
• Hypomagnesaemia (Suppressed Signal)
Other
• Cholecystitis acute (Suppressed Signal)
• AST/ALT ratio abnormal
• Mastoid disorder
• Cardiac assistance device user
• Brain natriuretic peptide increased
• Asymptomatic COVID-19 (Pfizer) (Suppressed Signal)
The FDA’s standard analytical method allegedly masked “obscured” statistical safety signals in the data
Aka they lied
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
The Chinese applied their tricks on Trump, giving him a smaller chair than the one the Chinese president sits on!
The discomfort on Trump's face is obvious, as Xi appears to be a head taller!
IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION
1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day).
LOW DOSE: ≤ 0.5 mg/kg/day
**Best for:**
- Cancers in remission
- Strong family history or genetic predisposition
- Prophylaxis (preventive)
**Side effects:** No long-term side effects reported.
**Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished.
MEDIUM DOSE: 1.0 mg/kg/day
**Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9.
HIGH DOSE: 2.0 mg/kg/day
**Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared.
VERY HIGH DOSE: ≥ 2.5 mg/kg/day
**Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers.
**Side effects:** Possible short-term & transient visual effects (usually resolve in a few days).
**Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported.
**Quick conversion example (for a 60 kg / 132 lb person):**
- Low: ≤30 mg/day
- Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid)
- High: 120 mg/day
- Very High: ≥150 mg/day
Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary.
Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only.
Share to spread awareness — information is power. 💊
TWO STUDIES FIND DANDELION ROOT AND LEMONGRASS SUPPRESS HUMAN CANCER GROWTH IN MICE BY 95%
Health Canada approved human cancer trials for dandelion root in 2012... then it was BURIED.
Backyard plants that HALT tumor growth in animals TERRIFY the Chemo Cartel.
BREAKING NEWS: First-in-the-World IVERMECTIN, Mebendazole and Fenbendazole Protocol for CANCER has been peer-reviewed and published!
I am seeing our paper everywhere recently, the NEWS is spreading! 😃
BIG PHARMA attacked our Fenbendazole paper on three Stage 4 Cancer patients who are now Cancer Free, but it will be resubmitted and published soon!
I have been attacked recently by Canadian authorities for my revolutionary Cancer research and work, but...
a NEW FLORIDA CANCER CLINIC is coming soon!🙏
Thank you all for your ongoing support!! 😃
God Bless you all and God bless those who are fighting Cancer...
-William Makis
French judge Nicolas Gouyou, who issued an arrest warrant for Netanyahu at the ICC:
• Visa and Mastercard have blocked all my cards
• I cannot make any purchases
• I am a judge, yet treated like a criminal
• Judges, lawyers, and politicians are being intimidated
• A colleague told me my name won’t be removed from the blacklist until Trump’s term ends
• Despite intervention by the French president, U.S. authorities have not responded
🚨BOTH lemongrass and dandelion root selectively destroy human cancer cells in the lab and suppress human tumor growth in mice by ~95% — with ZERO harm to healthy cells.
Common, non-toxic plants shown to HALT tumor growth in animal models deserve IMMEDIATE clinical trials.